Involvement	O
of	O
the	O
endocannabinoid	B:C3156138
system	I:C3156138
in	O
the	O
physiological	O
response	I:C0542478
to	O
transient	O
common	O
carotid	O
artery	I:C0265101
occlusion	I:C0265101
and	O
reperfusion	O
.	O

Involvement	O
of	O
the	O
endocannabinoid	O
system	I:C3156138
in	O
the	O
physiological	B:C0542478
response	I:C0542478
to	O
transient	O
common	O
carotid	O
artery	I:C0265101
occlusion	I:C0265101
and	O
reperfusion	O
.	O

Involvement	O
of	O
the	O
endocannabinoid	O
system	I:C3156138
in	O
the	O
physiological	O
response	I:C0542478
to	O
transient	O
common	O
carotid	B:C0265101
artery	I:C0265101
occlusion	I:C0265101
and	O
reperfusion	O
.	O

Involvement	O
of	O
the	O
endocannabinoid	O
system	I:C3156138
in	O
the	O
physiological	O
response	I:C0542478
to	O
transient	O
common	O
carotid	O
artery	I:C0265101
occlusion	I:C0265101
and	O
reperfusion	B:C0684253
.	O

The	O
transient	O
global	B:C1695782
cerebral	I:C1695782
hypoperfusion	I:C1695782
/	O
reperfusion	O
achieved	O
by	O
induction	O
of	O
Bilateral	O
Common	I:C1386627
Carotid	I:C1386627
Artery	I:C1386627
Occlusion	I:C1386627
followed	O
by	O
Reperfusion	O
(	O
BCCAO	O
/	O
R	O
)	O
may	O
trigger	O
a	O
physiological	O
response	I:C0542478
in	O
an	O
attempt	O
to	O
preserve	O
tissue	O
and	O
function	O
integrity	O
.	O

The	O
transient	O
global	O
cerebral	I:C1695782
hypoperfusion	I:C1695782
/	O
reperfusion	B:C0684253
achieved	O
by	O
induction	O
of	O
Bilateral	O
Common	I:C1386627
Carotid	I:C1386627
Artery	I:C1386627
Occlusion	I:C1386627
followed	O
by	O
Reperfusion	O
(	O
BCCAO	O
/	O
R	O
)	O
may	O
trigger	O
a	O
physiological	O
response	I:C0542478
in	O
an	O
attempt	O
to	O
preserve	O
tissue	O
and	O
function	O
integrity	O
.	O

The	O
transient	O
global	O
cerebral	I:C1695782
hypoperfusion	I:C1695782
/	O
reperfusion	O
achieved	O
by	O
induction	O
of	O
Bilateral	B:C1386627
Common	I:C1386627
Carotid	I:C1386627
Artery	I:C1386627
Occlusion	I:C1386627
followed	O
by	O
Reperfusion	O
(	O
BCCAO	O
/	O
R	O
)	O
may	O
trigger	O
a	O
physiological	O
response	I:C0542478
in	O
an	O
attempt	O
to	O
preserve	O
tissue	O
and	O
function	O
integrity	O
.	O

The	O
transient	O
global	O
cerebral	I:C1695782
hypoperfusion	I:C1695782
/	O
reperfusion	O
achieved	O
by	O
induction	O
of	O
Bilateral	O
Common	I:C1386627
Carotid	I:C1386627
Artery	I:C1386627
Occlusion	I:C1386627
followed	O
by	O
Reperfusion	B:C0684253
(	O
BCCAO	O
/	O
R	O
)	O
may	O
trigger	O
a	O
physiological	O
response	I:C0542478
in	O
an	O
attempt	O
to	O
preserve	O
tissue	O
and	O
function	O
integrity	O
.	O

The	O
transient	O
global	O
cerebral	I:C1695782
hypoperfusion	I:C1695782
/	O
reperfusion	O
achieved	O
by	O
induction	O
of	O
Bilateral	O
Common	I:C1386627
Carotid	I:C1386627
Artery	I:C1386627
Occlusion	I:C1386627
followed	O
by	O
Reperfusion	O
(	O
BCCAO	B:C1386627
/	O
R	O
)	O
may	O
trigger	O
a	O
physiological	O
response	I:C0542478
in	O
an	O
attempt	O
to	O
preserve	O
tissue	O
and	O
function	O
integrity	O
.	O

The	O
transient	O
global	O
cerebral	I:C1695782
hypoperfusion	I:C1695782
/	O
reperfusion	O
achieved	O
by	O
induction	O
of	O
Bilateral	O
Common	I:C1386627
Carotid	I:C1386627
Artery	I:C1386627
Occlusion	I:C1386627
followed	O
by	O
Reperfusion	O
(	O
BCCAO	O
/	O
R	B:C0684253
)	O
may	O
trigger	O
a	O
physiological	O
response	I:C0542478
in	O
an	O
attempt	O
to	O
preserve	O
tissue	O
and	O
function	O
integrity	O
.	O

The	O
transient	O
global	O
cerebral	I:C1695782
hypoperfusion	I:C1695782
/	O
reperfusion	O
achieved	O
by	O
induction	O
of	O
Bilateral	O
Common	I:C1386627
Carotid	I:C1386627
Artery	I:C1386627
Occlusion	I:C1386627
followed	O
by	O
Reperfusion	O
(	O
BCCAO	O
/	O
R	O
)	O
may	O
trigger	O
a	O
physiological	B:C0542478
response	I:C0542478
in	O
an	O
attempt	O
to	O
preserve	O
tissue	O
and	O
function	O
integrity	O
.	O

There	O
are	O
several	O
candidate	O
molecules	O
among	O
which	O
the	O
endocannabinoid	B:C3156138
system	I:C3156138
(	O
endocannabinoid	O
system	I:C3156138
)	O
and	O
/	O
or	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
(	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
)	O
may	O
play	O
a	O
role	O
in	O
modulating	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

There	O
are	O
several	O
candidate	O
molecules	O
among	O
which	O
the	O
endocannabinoid	O
system	I:C3156138
(	O
endocannabinoid	B:C3156138
system	I:C3156138
)	O
and	O
/	O
or	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
(	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
)	O
may	O
play	O
a	O
role	O
in	O
modulating	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

There	O
are	O
several	O
candidate	O
molecules	O
among	O
which	O
the	O
endocannabinoid	O
system	I:C3156138
(	O
endocannabinoid	O
system	I:C3156138
)	O
and	O
/	O
or	O
peroxisome	B:C0166415
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
(	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
)	O
may	O
play	O
a	O
role	O
in	O
modulating	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

There	O
are	O
several	O
candidate	O
molecules	O
among	O
which	O
the	O
endocannabinoid	O
system	I:C3156138
(	O
endocannabinoid	O
system	I:C3156138
)	O
and	O
/	O
or	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
(	O
peroxisome	B:C0166415
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
)	O
may	O
play	O
a	O
role	O
in	O
modulating	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

There	O
are	O
several	O
candidate	O
molecules	O
among	O
which	O
the	O
endocannabinoid	O
system	I:C3156138
(	O
endocannabinoid	O
system	I:C3156138
)	O
and	O
/	O
or	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
(	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
)	O
may	O
play	O
a	O
role	O
in	O
modulating	B:C0443264
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

There	O
are	O
several	O
candidate	O
molecules	O
among	O
which	O
the	O
endocannabinoid	O
system	I:C3156138
(	O
endocannabinoid	O
system	I:C3156138
)	O
and	O
/	O
or	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
(	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
)	O
may	O
play	O
a	O
role	O
in	O
modulating	O
oxidative	B:C0242606
stress	I:C0242606
and	O
inflammation	O
.	O

There	O
are	O
several	O
candidate	O
molecules	O
among	O
which	O
the	O
endocannabinoid	O
system	I:C3156138
(	O
endocannabinoid	O
system	I:C3156138
)	O
and	O
/	O
or	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
(	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
)	O
may	O
play	O
a	O
role	O
in	O
modulating	O
oxidative	O
stress	I:C0242606
and	O
inflammation	B:C0021368
.	O

The	O
aims	O
of	O
the	O
present	O
study	B:C0008972
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	B:C0220825
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	B:C3156138
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	B:C0014442
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	B:C0387583
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	B:C0387583
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	B:C0166415
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	B:C1386627
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	B:C0684253
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	B:C1882598
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	B:C0005516
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	B:C1386627
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	B:C0684253
-	O
induced	O
challenge	O
in	O
plasma	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
are	O
to	O
evaluate	O
whether	O
the	O
endocannabinoid	O
system	I:C3156138
,	O
the	O
enzyme	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
(	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
)	O
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
are	O
involved	O
during	O
BCCAO	O
/	O
R	O
in	O
rat	O
brain	I:C1882598
,	O
and	O
to	O
identify	O
possible	O
markers	O
of	O
the	O
ongoing	O
BCCAO	O
/	O
R	O
-	O
induced	O
challenge	O
in	O
plasma	B:C0032105
.	O

Adult	O
Wistar	B:C0034716
rats	I:C0034716
underwent	O
BCCAO	O
/	O
R	O
with	O
30	O
min	O
hypoperfusion	O
followed	O
by	O
60	O
min	O
reperfusion	O
.	O

Adult	O
Wistar	O
rats	I:C0034716
underwent	O
BCCAO	B:C1386627
/	O
R	O
with	O
30	O
min	O
hypoperfusion	O
followed	O
by	O
60	O
min	O
reperfusion	O
.	O

Adult	O
Wistar	O
rats	I:C0034716
underwent	O
BCCAO	O
/	O
R	B:C0684253
with	O
30	O
min	O
hypoperfusion	O
followed	O
by	O
60	O
min	O
reperfusion	O
.	O

Adult	O
Wistar	O
rats	I:C0034716
underwent	O
BCCAO	O
/	O
R	O
with	O
30	O
min	O
hypoperfusion	B:C0442856
followed	O
by	O
60	O
min	O
reperfusion	O
.	O

Adult	O
Wistar	O
rats	I:C0034716
underwent	O
BCCAO	O
/	O
R	O
with	O
30	O
min	O
hypoperfusion	O
followed	O
by	O
60	O
min	O
reperfusion	B:C0684253
.	O

The	O
frontal	B:C0016733
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	B:C0039485
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	B:C3811911
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	B:C0032105
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	B:C0936012
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	B:C3641325
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	B:C3641325
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	B:C1172779
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	B:C1172779
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	B:C0023688
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	B:C0166415
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	B:C0242606
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	B:C0005516
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	B:C0023776
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	B:C0949466
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	B:C0021044
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	B:C0008972
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	B:C1171362
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	B:C0054594
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	B:C0387583
-	I:C0387583
2	I:C0387583
and	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

The	O
frontal	O
and	O
temporal	O
-	O
occipital	O
cortices	I:C3811911
and	O
plasma	O
were	O
analyzed	O
by	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
(	O
high	O
performance	I:C3641325
liquid	I:C3641325
chromatography	I:C3641325
-	I:C3641325
mass	I:C3641325
spectrometry	I:C3641325
)	O
to	O
determine	O
concentrations	O
of	O
endocannabinoids	O
(	O
endocannabinoids	O
)	O
and	O
related	O
molecules	O
behaving	O
as	O
ligands	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
and	O
of	O
oxidative	O
-	I:C0242606
stress	I:C0242606
markers	O
such	O
as	O
lipoperoxides	O
,	O
while	O
Western	O
Blot	I:C0949466
and	O
immunohistochemistry	O
were	O
used	O
to	O
study	O
protein	O
expression	I:C1171362
of	O
cannabinoid	O
receptors	I:C0054594
,	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
and	O
peroxisome	B:C0166415
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
.	O

Unpaired	B:C1710574
Student	I:C1710574
's	I:C1710574
t-	I:C1710574
test	I:C1710574
was	O
used	O
to	O
evaluate	O
statistical	O
differences	O
between	O
groups	O
.	O

Unpaired	O
Student	I:C1710574
's	I:C1710574
t-	I:C1710574
test	I:C1710574
was	O
used	O
to	O
evaluate	B:C0220825
statistical	O
differences	O
between	O
groups	O
.	O

The	O
acute	O
BCCAO	B:C1386627
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	B:C0684253
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	B:C0459385
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	B:C1172779
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	B:C0299477
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	B:C0211726
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	B:C0069964
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	B:C0023688
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	B:C0166415
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	B:C0023776
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	B:C0378126
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	B:C0378126
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	B:C0208757
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	B:C0208757
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	B:C0054594
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	B:C0387583
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	B:C0459385
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	B:C0012968
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	B:C0012968
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	O
peroxidation	I:C0023775
.	O

The	O
acute	O
BCCAO	O
/	O
R	O
procedure	O
is	O
followed	O
by	O
increased	O
brain	O
tissue	I:C0459385
levels	O
of	O
the	O
endocannabinoids	O
2	O
-	I:C0299477
arachidonoylglycerol	I:C0299477
and	O
anandamide	O
,	O
palmitoylethanolamide	O
,	O
an	O
avid	O
ligand	O
of	O
peroxisome	O
-	I:C0166415
proliferator	I:C0166415
activated	I:C0166415
receptor	I:C0166415
-	I:C0166415
alpha	I:C0166415
,	O
lipoperoxides	O
,	O
type	O
1	I:C0378126
(	O
CB1	O
)	O
and	O
type	O
2	I:C0208757
(	O
CB2	O
)	O
cannabinoid	O
receptors	I:C0054594
,	O
and	O
cyclooxygenase	O
-	I:C0387583
2	I:C0387583
,	O
and	O
decreased	O
brain	O
tissue	I:C0459385
concentrations	O
of	O
docosahexaenoic	O
acid	I:C0012968
(	O
docosahexaenoic	O
acid	I:C0012968
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
lipid	B:C0023775
peroxidation	I:C0023775
.	O

In	O
plasma	B:C0032105
,	O
increased	O
levels	O
of	O
anandamide	O
and	O
lipoperoxides	O
were	O
observed	O
.	O

In	O
plasma	O
,	O
increased	O
levels	O
of	O
anandamide	B:C0211726
and	O
lipoperoxides	O
were	O
observed	O
.	O

In	O
plasma	O
,	O
increased	O
levels	O
of	O
anandamide	O
and	O
lipoperoxides	B:C0023776
were	O
observed	O
.	O

The	O
BCCAO	B:C1386627
/	O
R	O
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	O
tissue	I:C0459385
and	O
plasma	O
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	O
physiological	O
response	I:C0542478
to	O
the	O
reperfusion	O
-	O
induced	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

The	O
BCCAO	O
/	O
R	B:C0684253
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	O
tissue	I:C0459385
and	O
plasma	O
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	O
physiological	O
response	I:C0542478
to	O
the	O
reperfusion	O
-	O
induced	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

The	O
BCCAO	O
/	O
R	O
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	B:C0459385
tissue	I:C0459385
and	O
plasma	O
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	O
physiological	O
response	I:C0542478
to	O
the	O
reperfusion	O
-	O
induced	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

The	O
BCCAO	O
/	O
R	O
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	O
tissue	I:C0459385
and	O
plasma	B:C0032105
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	O
physiological	O
response	I:C0542478
to	O
the	O
reperfusion	O
-	O
induced	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

The	O
BCCAO	O
/	O
R	O
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	O
tissue	I:C0459385
and	O
plasma	O
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	B:C0040300
physiological	O
response	I:C0542478
to	O
the	O
reperfusion	O
-	O
induced	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

The	O
BCCAO	O
/	O
R	O
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	O
tissue	I:C0459385
and	O
plasma	O
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	O
physiological	B:C0542478
response	I:C0542478
to	O
the	O
reperfusion	O
-	O
induced	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

The	O
BCCAO	O
/	O
R	O
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	O
tissue	I:C0459385
and	O
plasma	O
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	O
physiological	O
response	I:C0542478
to	O
the	O
reperfusion	B:C0684253
-	O
induced	O
oxidative	O
stress	I:C0242606
and	O
inflammation	O
.	O

The	O
BCCAO	O
/	O
R	O
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	O
tissue	I:C0459385
and	O
plasma	O
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	O
physiological	O
response	I:C0542478
to	O
the	O
reperfusion	O
-	O
induced	O
oxidative	B:C0242606
stress	I:C0242606
and	O
inflammation	O
.	O

The	O
BCCAO	O
/	O
R	O
stimulated	O
early	O
molecular	O
changes	O
that	O
can	O
be	O
easily	O
traced	O
in	O
brain	O
tissue	I:C0459385
and	O
plasma	O
,	O
and	O
that	O
are	O
indicative	O
of	O
the	O
tissue	O
physiological	O
response	I:C0542478
to	O
the	O
reperfusion	O
-	O
induced	O
oxidative	O
stress	I:C0242606
and	O
inflammation	B:C0021368
.	O

The	O
observed	O
variations	O
suggest	O
that	O
the	O
positive	O
modulation	B:C0443264
of	O
the	O
endocannabinoid	O
system	I:C3156138
and	O
the	O
increase	O
of	O
proinflammatory	O
substances	O
are	O
directly	O
correlated	O
events	O
.	O

The	O
observed	O
variations	O
suggest	O
that	O
the	O
positive	O
modulation	O
of	O
the	O
endocannabinoid	B:C3156138
system	I:C3156138
and	O
the	O
increase	O
of	O
proinflammatory	O
substances	O
are	O
directly	O
correlated	O
events	O
.	O

The	O
observed	O
variations	O
suggest	O
that	O
the	O
positive	O
modulation	O
of	O
the	O
endocannabinoid	O
system	I:C3156138
and	O
the	O
increase	O
of	O
proinflammatory	B:C0574031
substances	O
are	O
directly	O
correlated	O
events	O
.	O

Increase	O
of	O
plasmatic	B:C0032105
levels	O
of	O
anandamide	O
and	O
lipoperoxides	O
further	O
suggests	O
that	O
dysregulation	O
of	O
these	O
molecules	O
may	O
be	O
taken	O
as	O
an	O
indicator	O
of	O
an	O
ongoing	O
hypoperfusion	O
/	O
reperfusion	O
challenge	O
.	O

Increase	O
of	O
plasmatic	O
levels	O
of	O
anandamide	B:C0211726
and	O
lipoperoxides	O
further	O
suggests	O
that	O
dysregulation	O
of	O
these	O
molecules	O
may	O
be	O
taken	O
as	O
an	O
indicator	O
of	O
an	O
ongoing	O
hypoperfusion	O
/	O
reperfusion	O
challenge	O
.	O

Increase	O
of	O
plasmatic	O
levels	O
of	O
anandamide	O
and	O
lipoperoxides	B:C0023776
further	O
suggests	O
that	O
dysregulation	O
of	O
these	O
molecules	O
may	O
be	O
taken	O
as	O
an	O
indicator	O
of	O
an	O
ongoing	O
hypoperfusion	O
/	O
reperfusion	O
challenge	O
.	O

Increase	O
of	O
plasmatic	O
levels	O
of	O
anandamide	O
and	O
lipoperoxides	O
further	O
suggests	O
that	O
dysregulation	B:C1327622
of	O
these	O
molecules	O
may	O
be	O
taken	O
as	O
an	O
indicator	O
of	O
an	O
ongoing	O
hypoperfusion	O
/	O
reperfusion	O
challenge	O
.	O

Increase	O
of	O
plasmatic	O
levels	O
of	O
anandamide	O
and	O
lipoperoxides	O
further	O
suggests	O
that	O
dysregulation	O
of	O
these	O
molecules	O
may	O
be	O
taken	O
as	O
an	O
indicator	O
of	O
an	O
ongoing	O
hypoperfusion	B:C0442856
/	O
reperfusion	O
challenge	O
.	O

Increase	O
of	O
plasmatic	O
levels	O
of	O
anandamide	O
and	O
lipoperoxides	O
further	O
suggests	O
that	O
dysregulation	O
of	O
these	O
molecules	O
may	O
be	O
taken	O
as	O
an	O
indicator	O
of	O
an	O
ongoing	O
hypoperfusion	O
/	O
reperfusion	B:C0684253
challenge	O
.	O

